Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siguo Hao

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
The Journal of International Medical Research|October 24, 2019
Successful treatment of diffuse large B-cell lymphoma with secondary hemophagocytic lymphohistiocytosis by R-CHOP-E regimen: a case reportRan Wu, Xiaohui Deng, Siguo Hao, et al.
Clinics (Sao Paulo, Brazil)|January 27, 2025
Efficacy and safety of a modified DVD regimen followed by lenalidomide for the treatment of Newly Diagnosed Multiple MyelomaZhichao Li, Wenhao Zhang, Fang Huang, et al.
Experimental Oncology|April 7, 2005
A novel approach to tumor suppression using microencapsulated engineered J558/TNF-alpha cellsSiguo Hao, Liping Su, Xulin Guo, et al.
Cellular & Molecular Immunology|August 9, 2006
Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomesSiguo Hao, Ou Bai, Jinying Yuan, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 19, 2006
Intradermal vaccination of dendritic cell-derived exosomes is superior to a subcutaneous one in the induction of antitumor immunitySiguo Hao, Zhenmin Ye, Jicheng Yang, et al.
Cancer Immunology, Immunotherapy : CII|January 29, 2022
Enhancing the anti-leukemia immunity of acute lymphocytic leukemia-derived exosome-based vaccine by downregulation of PD-L1 expressionFang Huang, Zhichao Li, Wenhao Zhang, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 25, 2020
Enhanced immunogenicity of leukemia-derived exosomes via transfection with lentiviral vectors encoding costimulatory moleculesWeiwei Hu, Fang Huang, Liuxin Ning, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2006
Oncolytic adenovirus-mediated E1A gene therapy induces tumor-cell apoptosis and reduces tumor angiogenesis leading to inhibition of hepatocellular carcinoma growth in animal modelZhenmin Ye, Xiaohua Wang, Siguo Hao, et al.
Frontiers in Bioscience (Landmark Edition)|September 8, 2025
Inhibition of Galectin-3 Expression Could Preserve the Immunoregulatory Function of Mesenchymal Stem Cells During Cell PassagingMinghui Wang, Yan Jiang, Jiangbo Wan, et al.
Biochemical and Biophysical Research Communications|May 28, 2013
Tumor cell-derived exosome-targeted dendritic cells stimulate stronger CD8+ CTL responses and antitumor immunitiesYe Yao, Linjun Chen, Wei Wei, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
The Journal of International Medical Research|October 24, 2019
Successful treatment of diffuse large B-cell lymphoma with secondary hemophagocytic lymphohistiocytosis by R-CHOP-E regimen: a case reportRan Wu, Xiaohui Deng, Siguo Hao, et al.
Clinics (Sao Paulo, Brazil)|January 27, 2025
Efficacy and safety of a modified DVD regimen followed by lenalidomide for the treatment of Newly Diagnosed Multiple MyelomaZhichao Li, Wenhao Zhang, Fang Huang, et al.
Experimental Oncology|April 7, 2005
A novel approach to tumor suppression using microencapsulated engineered J558/TNF-alpha cellsSiguo Hao, Liping Su, Xulin Guo, et al.
Cellular & Molecular Immunology|August 9, 2006
Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomesSiguo Hao, Ou Bai, Jinying Yuan, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 19, 2006
Intradermal vaccination of dendritic cell-derived exosomes is superior to a subcutaneous one in the induction of antitumor immunitySiguo Hao, Zhenmin Ye, Jicheng Yang, et al.
Cancer Immunology, Immunotherapy : CII|January 29, 2022
Enhancing the anti-leukemia immunity of acute lymphocytic leukemia-derived exosome-based vaccine by downregulation of PD-L1 expressionFang Huang, Zhichao Li, Wenhao Zhang, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 25, 2020
Enhanced immunogenicity of leukemia-derived exosomes via transfection with lentiviral vectors encoding costimulatory moleculesWeiwei Hu, Fang Huang, Liuxin Ning, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2006
Oncolytic adenovirus-mediated E1A gene therapy induces tumor-cell apoptosis and reduces tumor angiogenesis leading to inhibition of hepatocellular carcinoma growth in animal modelZhenmin Ye, Xiaohua Wang, Siguo Hao, et al.
Frontiers in Bioscience (Landmark Edition)|September 8, 2025
Inhibition of Galectin-3 Expression Could Preserve the Immunoregulatory Function of Mesenchymal Stem Cells During Cell PassagingMinghui Wang, Yan Jiang, Jiangbo Wan, et al.
Biochemical and Biophysical Research Communications|May 28, 2013
Tumor cell-derived exosome-targeted dendritic cells stimulate stronger CD8+ CTL responses and antitumor immunitiesYe Yao, Linjun Chen, Wei Wei, et al.
Pageof 7